Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report. - Wikidata - awgldk - TriplyDB

Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report.

Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report.

http://www.wikidata.org/entity/Q37406827

about

Histone deacetylases in monocyte/macrophage development, activation and metabolism: refining HDAC targets for inflammatory and infectious diseases Increased Levels of Plasma Epstein Barr Virus DNA Identify a Poor-Risk Subset of Patients With Advanced Stage Cutaneous T-Cell Lymphoma The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment.Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors.Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma.Romidepsin: in the treatment of T-cell lymphoma.Occult hepatitis B virus and hepatocellular carcinoma Viral response to chemotherapy in endemic burkitt lymphoma Augmenting antitumor immune responses with epigenetic modifying agents.Romidepsin in the treatment of cutaneous T-cell lymphoma.Hepatitis B Virus Reactivation during Treatment with Multi-Tyrosine Kinase Inhibitor for Hepatocellular Carcinoma Occult HBV infection.Inhibition of cell-mediated immunity by the histone deacetylase inhibitor vorinostat: implications for therapy of cutaneous T-cell lymphoma.The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T-cell lymphoma patients.Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder.The emerging role of histone deacetylase inhibitors in treating T-cell lymphomas.HDAC inhibitors in HIV.Small-molecule chromatin-modifying agents: therapeutic applications.Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders.Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions.Epstein-Barr virus reactivation in extranodal natural killer/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsin.Virus-host interplay in hepatitis B virus infection and epigenetic treatment strategies.HIV-hepatitis B virus co-infection: epidemiology, pathogenesis, and treatment.Primary macrophages rely on histone deacetylase 1 and 2 expression to induce type I interferon in response to gammaherpesvirus infection.JSH Guidelines for the Management of Hepatitis B Virus Infection.The clinical significance of occult HBV infection.Reply to the letter to the editor 'Epstein-Barr virus reactivation in extranodal natural killer/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsin, histone deacetylase (HDAC) inhibitors when co

P2860

Q26768497-30141A07-A1C6-4A96-B1A2-F100F9F45E86 Q30276132-64E63449-796B-4B29-A178-4A3401991FCA Q30278553-CBE33E7E-21AB-4AFE-AE20-594A115F13AF Q30936712-057ECFBC-173B-4E68-B40D-E8AC718C87E2 Q33390876-C10C3320-340F-4718-B629-E3561B2898A5 Q33394324-47B3537E-74DB-4464-9849-447100116759 Q33396519-D05030BA-34C9-4ECB-8E98-5F16AEAADCAB Q33661018-251A9EC8-8143-4A22-AEA4-3D4230C7C12D Q33767066-A062561F-4826-4653-B06B-1BA1EFAA6D9D Q35048054-78802A94-AD25-45F3-A578-3E2A0306E712 Q35683831-1287E018-7216-433E-8F4B-11B261782EEC Q36382891-1F87B841-9D33-4F5F-8023-C502A78BB3B5 Q36518847-F318EE57-DE5D-426A-98BA-EBDD73E1BE6D Q36770311-A767A39A-9F0C-43E2-A2F3-26FC0C1C4859 Q36802272-91EEF0BD-3112-469A-8F1C-A723534252D7 Q37726624-A123053F-4775-40D0-A55A-F4425B4B7E1A Q37809805-CF52205A-CE2D-423A-9314-A31E1A430DA1 Q37956178-B4C12A1D-A44A-49D2-9B96-9F4B71C839F5 Q37961728-030CCC23-3F36-42CB-83D7-D30A0E0F0299 Q38240733-67934BB3-8940-42DD-A09E-A643EF558C45 Q38755178-75C7C136-DC25-43B9-B286-E0765B49C31F Q38812282-D3A6BEAD-6952-40C9-87B5-D274C7590119 Q39272853-23839313-66DE-46CA-A8C4-C4552AD68E4A Q39425755-38A194F3-3F34-4DD8-9E92-3F6D63AB6D2D Q41908887-09FF5594-F3DB-4807-A650-955F662B9BB0 Q42244740-ED04A6CF-A9FD-4EE9-8D5B-8CF7F9F258CE Q42406515-4AAAF6DA-D34E-4423-92B6-38403D53A419 Q44500443-945D11CA-7E6A-444F-A849-0F949B545EEF

P2860

Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report.

http://www.wikidata.org/entity/Q37406827

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Reactivation of DNA viruses in ...... therapy: a case series report.

@en

Reactivation of DNA viruses in ...... therapy: a case series report.

@nl

type

label

Reactivation of DNA viruses in ...... therapy: a case series report.

@en

Reactivation of DNA viruses in ...... therapy: a case series report.

@nl

prefLabel

Reactivation of DNA viruses in ...... therapy: a case series report.

@en

Reactivation of DNA viruses in ...... therapy: a case series report.

@nl

P1433

Q37406827-BE5C5498-E2A4-4AF0-A93B-3C811D29654E

P1476

Q37406827-6FEA0F53-E6EB-47C7-B218-95B6F57F3111

P2093

Q37406827-0C13BE8E-A2AB-4DB4-A23A-7B070EAB01FA

Q37406827-10F43E34-4D93-418A-B016-5BC4279BF9FD

Q37406827-1AEE086A-0B22-4817-8DED-7E10C617A020

Q37406827-23FFE806-3691-4511-BA8B-C673F74A8582

Q37406827-2BF69120-70FC-45B8-A397-6EF2A976D769

Q37406827-45027D61-291B-4D0F-9D48-D88126435C71

Q37406827-7F3B4430-762C-4D86-8D9D-5831F3BB17CD

Q37406827-ACD42A90-3295-4F8F-B7C6-F7CC56C599AA

Q37406827-D2D41126-C7A3-4F99-BBD5-401D7F63C440

Q37406827-E1C0A469-3DB6-4DE0-9700-2F3514B7E752

P2860

Q37406827-043094CA-4EC6-43AF-8B54-5DEB5C8BC411

Q37406827-071EFEE0-BA3E-4673-8356-593D7E77B8BB

Q37406827-0BC40D9E-EDDE-4A32-85BE-CA4D5BCD50D1

Q37406827-13935A2A-83BE-4B9B-885F-D98F8DCFD7F5

Q37406827-18DC1BCD-7F7E-4A59-B355-72A1AD5E304C

Q37406827-23C61B42-3612-4DF5-AE3B-9222F4CF54BC

Q37406827-2866C4FF-4B25-468B-A060-4EDC4E6F91A0

Q37406827-2FE121EC-6CC8-4411-9A10-6184C3189DAC

Q37406827-3FAA82BA-DA41-4C44-82A0-434C495E9261

Q37406827-4E31264C-96C0-44F6-BF52-D595362B1DC5

P304

Q37406827-FB622296-8CCF-41D7-B150-E572FC04E212

P31

Q37406827-E834FE9C-0F6D-4881-AA03-C81E06E6D470

P356

Q37406827-40EB5DC8-9E2A-4301-A3CF-6ECE4609B30D

P433

Q37406827-09CDBFF4-4877-47B2-BBAB-05C7320EEB7E

P478

Q37406827-624E4C14-4497-4CC4-A266-577FFD5CF073

P577

Q37406827-D4788685-00F1-4B83-9F2A-EC3515DC3C7D

P5875

Q37406827-BE638460-3DBF-4AB0-B885-F3E18F3124F3

P698

Q37406827-44CE87C3-588B-49D1-9E1B-8E689F2747A0

P932

Q37406827-B700BBD5-CD7C-4FF5-8DA9-A6A7260CEACF

P356

HAEMATOL.2009.008607

P1433

P1476

Reactivation of DNA viruses in ...... therapy: a case series report.

@en

P2093

David Ritchie

http://www.w3.org/2001/XMLSchema#string

Elaine S Jaffe

http://www.w3.org/2001/XMLSchema#string

H Miles Prince

http://www.w3.org/2001/XMLSchema#string

John E Janik

http://www.w3.org/2001/XMLSchema#string

Laszlo J Karai

http://www.w3.org/2001/XMLSchema#string

Mark Raffeld

http://www.w3.org/2001/XMLSchema#string

Piers Blombery

http://www.w3.org/2001/XMLSchema#string

Richard L Piekarz

http://www.w3.org/2001/XMLSchema#string

Stefania Pittaluga

http://www.w3.org/2001/XMLSchema#string

Susan E Bates

http://www.w3.org/2001/XMLSchema#string

P2860

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

Lymphocyte chemotaxis is regulated by histone deacetylase 6, independently of its deacetylase activity.

Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma.

Epstein-Barr virus infection.

Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis

Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase.

A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells.

Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy.

Chromatin regulation of virus infection.

De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.

P304

1618-1622

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2009.008607

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26676499

http://www.w3.org/2001/XMLSchema#string

P698

19608677

http://www.w3.org/2001/XMLSchema#string

P932

2770976

http://www.w3.org/2001/XMLSchema#string